冠状动脉狭窄与冠状动脉粥样硬化的临床定量影像学:定量心血管影像研究组的共识声明
该共识声明针对已知或疑似冠心病患者,通过三步实时德尔菲法形成临床共识推荐,阐述不同影像技术在直接显示冠状动脉方面的适用性。CT是中等验前概率患者排除阻塞性狭窄的首选方法并可定量评估斑块,MRI可作为无辐射的二线选择,PET在斑块炎症定量方面潜力最大,有创冠状动脉造影是狭窄评估的参考标准但无法表征斑块。
要点
- CT是中等验前概率患者排除阻塞性狭窄的首选方法,并可定量评估斑块尺寸、成分、位置及未来心血管事件风险。
- 有创冠状动脉造影是狭窄评估的参考标准,但不能表征冠状动脉斑块。
- 血管内超声和光学相干断层扫描是识别高破裂风险斑块最重要的有创影像方式。
核心结论
- CT是中等验前概率患者排除阻塞性狭窄的首选方法,并可定量评估斑块尺寸、成分、位置及未来心血管事件风险。
- MRI可显示冠状动脉斑块,在有经验的中心可作为无辐射的二线非侵入性冠状动脉造影选择。
- PET在定量斑块炎症方面潜力最大,SPECT目前在该领域作用有限。
- 有创冠状动脉造影是狭窄评估的参考标准但不能表征斑块,血管内超声和光学相干断层扫描是识别高破裂风险斑块最重要的有创方式。
研究设计与样本
- 该文件为定量心血管影像研究组的共识声明,临床共识推荐通过三步实时德尔菲法得出,该过程在2022年9月第二届国际定量心血管影像会议之前、期间和之后进行。
诊断标准与关键数值
- 根据德尔菲调查答案,CT是中等验前概率冠心病患者排除阻塞性狭窄的首选方法。
- MRI在有经验的中心可作为无辐射的二线非侵入性冠状动脉造影选择。
- 有创冠状动脉造影是狭窄评估的参考标准,但不能表征冠状动脉斑块。
临床应用与阅片要点
- 应根据具体临床场景、患者个体特征及每种影像方式的可用性选择最合适的影像方式。
- CT可用于中等验前概率患者排除阻塞性狭窄并定量评估斑块尺寸、成分、位置及未来心血管事件风险。
- MRI可在有经验的中心作为无辐射的二线非侵入性冠状动脉造影选择。
- PET在定量斑块炎症方面潜力最大,SPECT目前作用有限。
- 血管内超声和光学相干断层扫描是识别高破裂风险斑块最重要的有创方式。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The detection and characterization of coronary artery stenosis and atherosclerosis using imaging tools are key for clinical decision-making in patients with known or suspected coronary artery disease. In this regard, imaging-based quantification can be improved by choosing the most appropriate imaging modality for diagnosis, treatment and procedural planning. In this Consensus Statement, we provide clinical consensus recommendations on the optimal use of different imaging techniques in various patient populations and describe the advances in imaging technology. Clinical consensus recommendations on the appropriateness of each imaging technique for direct coronary artery visualization were derived through a three-step, real-time Delphi process that took place before, during and after the Second International Quantitative Cardiovascular Imaging Meeting in September 2022. According to the Delphi survey answers, CT is the method of choice to rule out obstructive stenosis in patients with an intermediate pre-test probability of coronary artery disease and enables quantitative assessment of coronary plaque with respect to dimensions, composition, location and related risk of future cardiovascular events, whereas MRI facilitates the visualization of coronary plaque and can be used in experienced centres as a radiation-free, second-line option for non-invasive coronary angiography. PET has the greatest potential for quantifying inflammation in coronary plaque but SPECT currently has a limited role in clinical coronary artery stenosis and atherosclerosis imaging. Invasive coronary angiography is the reference standard for stenosis assessment but cannot characterize coronary plaques. Finally, intravascular ultrasonography and optical coherence tomography are the most important invasive imaging modalities for the identification of plaques at high risk of rupture. The recommendations made in this Consensus Statement will help clinicians to choose the most appropriate imaging modality on the basis of the specific clinical scenario, individual patient characteristics and the availability of each imaging modality.
引用
- Mézquita, Biavati, Falk, et al. Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study Group. Nat Rev Cardiol. 2023. PMID: 37277608. doi:10.1038/s41569-023-00880-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。